Correlation Between Edgewise Therapeutics and Biohaven Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both Edgewise Therapeutics and Biohaven Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edgewise Therapeutics and Biohaven Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edgewise Therapeutics and Biohaven Pharmaceutical Holding, you can compare the effects of market volatilities on Edgewise Therapeutics and Biohaven Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edgewise Therapeutics with a short position of Biohaven Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edgewise Therapeutics and Biohaven Pharmaceutical.
Diversification Opportunities for Edgewise Therapeutics and Biohaven Pharmaceutical
0.87 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Edgewise and Biohaven is 0.87. Overlapping area represents the amount of risk that can be diversified away by holding Edgewise Therapeutics and Biohaven Pharmaceutical Holdin in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biohaven Pharmaceutical and Edgewise Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edgewise Therapeutics are associated (or correlated) with Biohaven Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biohaven Pharmaceutical has no effect on the direction of Edgewise Therapeutics i.e., Edgewise Therapeutics and Biohaven Pharmaceutical go up and down completely randomly.
Pair Corralation between Edgewise Therapeutics and Biohaven Pharmaceutical
Given the investment horizon of 90 days Edgewise Therapeutics is expected to generate 0.78 times more return on investment than Biohaven Pharmaceutical. However, Edgewise Therapeutics is 1.28 times less risky than Biohaven Pharmaceutical. It trades about -0.06 of its potential returns per unit of risk. Biohaven Pharmaceutical Holding is currently generating about -0.11 per unit of risk. If you would invest 3,332 in Edgewise Therapeutics on August 31, 2024 and sell it today you would lose (112.00) from holding Edgewise Therapeutics or give up 3.36% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Edgewise Therapeutics vs. Biohaven Pharmaceutical Holdin
Performance |
| Timeline |
| Edgewise Therapeutics |
| Biohaven Pharmaceutical |
Edgewise Therapeutics and Biohaven Pharmaceutical Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Edgewise Therapeutics and Biohaven Pharmaceutical
The main advantage of trading using opposite Edgewise Therapeutics and Biohaven Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edgewise Therapeutics position performs unexpectedly, Biohaven Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biohaven Pharmaceutical will offset losses from the drop in Biohaven Pharmaceutical's long position.| Edgewise Therapeutics vs. Cue Biopharma | Edgewise Therapeutics vs. Eliem Therapeutics | Edgewise Therapeutics vs. Inhibrx | Edgewise Therapeutics vs. Molecular Partners AG |
| Biohaven Pharmaceutical vs. Immunome | Biohaven Pharmaceutical vs. Inhibrx | Biohaven Pharmaceutical vs. Day One Biopharmaceuticals | Biohaven Pharmaceutical vs. Terns Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |